Table 4.
Odds ratio and 95% confidence interval (CI) for the association between leiomyoma and log transformed creatinine-adjusted urinary phthalate levels.
| Urine Level (µg/g Creatinine) | Crude OR (95% CI) | Adjusted OR a (95% CI) | Adjusted OR b (95% CI) |
|---|---|---|---|
| MEHP | 3.75 (1.17–12.0) | 4.08 (0.89–18.60) | 4.17 (0.90–19.40) |
| MEOHP | 2.83 (0.81–9.87) | 3.82 (0.71–20.60) | 3.71 (0.71–20.80) |
| MEHHP | 3.63 (0.93–14.20) | 5.43 (0.84–35.20) | 5.52 (0.83–36.57) |
| 2cx-MMHP | 3.87 (0.86–17.30) | 3.08 (0.63–15.10) | 3.10 (0.63–15.12) |
| 5cx-MEPP | 2.76 (0.73–10.37) | 2.95 (0.58–15.02) | 2.95 (0.58–14.96) |
| ∑3-DEHP * | 6.04 (1.24–29.37) | 10.82 (1.25–93.46) | 10.78 (1.24–93.81) |
| ∑4-DEHP ** | 5.73 (1.10–29.74) | 8.78 (1.03–72.29) | 8.61 (1.00–74.02) |
| ∑5-DEHP *** | 6.18 (1.07–35.86) | 8.24 (0.86–79.10) | 8.01 (0.84–76.0) |
| ∑2-DEHP **** | 3.53 (0.78–15.84) | 3.29 (0.58–18.63) | 3.30 (0.59–18.55) |
| MBzP | 1.06 (0.23–5.80) | 1.27 (0.16–6.81) | 1.17 (0.17–8.18) |
| MiBP | 1.42 (0.31–6.54) | 2.12 (0.29–15.42) | 2.15 (0.29–15.80) |
| MEP | 1.09 (0.39–3.07) | 1.27 (0.36–4.44) | 1.63 (0.39–6.75) |
| MMP | 1.51 (0.58–3.95) | 1.26 (0.40–3.95) | 1.15 (0.35–3.84) |
All phthalate metabolites were creatinine (mg/dL) standardized. a Adjusted for age, waist circumference, and parity; b Adjusted for age, waist circumference, parity, and smoking status; * ∑3-DEHP is the molar sum of MEHP, MEHHP, and MEOHP; ** ∑4-DEHP is the molar sum of MEHP, MEHHP, MEOHP, and 5cx-MEPP; *** ∑5-DEHP is the molar sum of MEHP, MEHHP, MEOHP, 5cx-MEPP, and 2cx-MMHP; **** ∑2-DEHP is the molar sum of 5cx-MEPP and 2cx-MMHP.